1/21/2025China's Biopharma R&D Expands Global Influence in 2024

1/20/2025InflamaX Secures Pre-A Investment for Immuno-Inflammatory Research  

1/20/2025Junshi and LEO Enter Commercialization Partnership for Toripalimab in ...

1/20/2025InnoCare and KeyMed Jointly Enter License Deal with Prolium for CD20xC...

1/20/2025NMPA Expands Label for Kelun-Biotech's Tagitanlimab in First-Line NPC ...

1/20/2025NMPA Expands Label for Genrix Bio's Xeligekimab in Radiographic AS

1/20/2025JOINN Biologics Acquires Lonza's Large Molecule CDMO Facility in Guang...

1/20/2025China Looks Into Generic Drug Quality After Doctors Speak Up (Bloomber...

1/17/2025Simnova and Orna Expand Partnership to Include BCMA-Targeted RNA Thera...

1/16/2025CDE Issues the Technical Guidelines for Clinical Risk Management Plans...

1/16/2025NHSA Issues Notice on Advancing Real-Time Settlement Reform for BMI Fu...

1/16/2025Alphamab Advances Oncology Pipeline with Phase 2 Trial of TROP-2/HER3 ...

1/16/2025Menarini and Insilico Forge Strategic Partnership to Address Unmet Nee...

1/16/2025'The Bar Has Risen': China's Biotech Gains Push US Companies to Adapt ...

1/16/2025The Rise of China Innovation in the Time of Trump (BioSpace)

1/15/2025China Biopharma Tracker 2024 (PharmaDJ)

1/15/2025China Announces Major Policy Incentives for Life Sciences Companies (R...

1/15/2025Evolving innovation strategies in China for multinational companies (A...

1/15/2025At JPM, Biotech Industry Expresses Excitement — and Some Anxiety — A...

1/15/2025Chengdu MedGenCell Secures Strategic Investment for Cell Therapy Innov...

1/15/2025U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...

1/14/2025Ikena and Inmagene Biopharma Agree to Merger Deal

1/14/2025CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...

1/14/2025ImmuneOnco Begins Trial of Instil's NSCLC Drug in China

1/14/2025NHSA Hosts Roundtable on Supporting Innovative Drug Development

1/13/2025AbbVie and Simcere Zaiming Forge Partnership for a Novel Trispecific A...

1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)

1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection

1/13/2025NMPA Announces Package Insert Revision of Human Albumin Injection

1/12/2025Imunopharm Secures Series E Financing to Support IM19 Commercializatio...

Page:24/370 Total number of articles:11087: [First][<<] [22] [23] [24] [25] [26] [>>] [End]